Discovery Early Career Researcher Award - Grant ID: DE160100134
Funder
Australian Research Council
Funding Amount
$323,088.00
Summary
Addiction in the Australian legal system: A sociological analysis. This project is designed to analyse and compare legal approaches to addiction to alcohol and other drugs (AOD), identifying the strengths and weaknesses of different approaches. Harms associated with AOD cost Australia over $25 billion per year. The law plays a central role in managing these harms. Yet legal responses to AOD and the key concept of ‘addiction’ are often inconsistent. These variations have unintended and often adve ....Addiction in the Australian legal system: A sociological analysis. This project is designed to analyse and compare legal approaches to addiction to alcohol and other drugs (AOD), identifying the strengths and weaknesses of different approaches. Harms associated with AOD cost Australia over $25 billion per year. The law plays a central role in managing these harms. Yet legal responses to AOD and the key concept of ‘addiction’ are often inconsistent. These variations have unintended and often adverse economic, social and health implications. The expected project outcomes will inform new, more productive approaches to AOD-related harms in Australian law, contributing to improved economic, social and health outcomes.Read moreRead less
Improving social, economic and health outcomes through drug policy reforms. Globally, recognition is growing that common prohibitionist drug policies contribute to drug-related harms and have not succeeded. Identified harms include the current drug overdose crisis in North America and a surge in overdose deaths in Australia, adding new force to calls for urgent reform. This project aims to respond to these calls by exploring how human rights considerations can inform improvements to drug policy. ....Improving social, economic and health outcomes through drug policy reforms. Globally, recognition is growing that common prohibitionist drug policies contribute to drug-related harms and have not succeeded. Identified harms include the current drug overdose crisis in North America and a surge in overdose deaths in Australia, adding new force to calls for urgent reform. This project aims to respond to these calls by exploring how human rights considerations can inform improvements to drug policy. The project seeks to generate new knowledge on how human rights can guide reform so as to improve social, economic and health outcomes. The project should provide significant benefits to the nation, informing Australian legal, policy and practice reforms as well as international efforts to reduce drug-related harms.Read moreRead less
Work Experience: Labour Law at the Intersection of Work and Education. This project aims to examine the regulatory challenges relating to post-secondary work experience, such as internships, in the areas of labour and employment, anti-discrimination and workers compensation law in Australia. The analysis is designed to establish a global and comparative context, examining policy and regulatory responses in Canada, Europe (including Britain), New Zealand, and the United States of America and at t ....Work Experience: Labour Law at the Intersection of Work and Education. This project aims to examine the regulatory challenges relating to post-secondary work experience, such as internships, in the areas of labour and employment, anti-discrimination and workers compensation law in Australia. The analysis is designed to establish a global and comparative context, examining policy and regulatory responses in Canada, Europe (including Britain), New Zealand, and the United States of America and at the international level. By offering a comprehensive analysis of the theoretical and practical implications of law's boundary between work and education, it is expected to identify optimum approaches to the regulation of post-secondary work experience, and thereby expand policy debates and enhance future law reform.Read moreRead less
Regulating Autologous Stem Cell Therapies in Australia. This project aims to develop an ethical and regulatory framework for the use of autologous adult stem cell therapies in Australia. These therapies are increasingly being offered to patients for diseases and conditions that lack scientific evidence of safety and efficacy. This study aims to address this problem using a mixed methods approach to generate empirical data and theoretical, ethical and legal insights that will guide the responsibl ....Regulating Autologous Stem Cell Therapies in Australia. This project aims to develop an ethical and regulatory framework for the use of autologous adult stem cell therapies in Australia. These therapies are increasingly being offered to patients for diseases and conditions that lack scientific evidence of safety and efficacy. This study aims to address this problem using a mixed methods approach to generate empirical data and theoretical, ethical and legal insights that will guide the responsible development, translation and regulation of innovative stem cell therapies in Australia and internationally. Anticipated outcomes will improve patient advocacy and public knowledge about adult stem cell therapies, and facilitate better relationships between patients, researchers and clinicians.Read moreRead less
Material Transfer Agreements and Open Science in the Genome Era. Research paradigms are changing rapidly in the Genome Era. Open access databases are increasingly popular and are required by public funding agencies. The role of material transfer agreements (MTAs) in this open access era is not clear. This project aims to assess the extent to which MTAs facilitate exchanges of biological materials between organisation in Australia and internationally. The project will assess whether MTAs are refl ....Material Transfer Agreements and Open Science in the Genome Era. Research paradigms are changing rapidly in the Genome Era. Open access databases are increasingly popular and are required by public funding agencies. The role of material transfer agreements (MTAs) in this open access era is not clear. This project aims to assess the extent to which MTAs facilitate exchanges of biological materials between organisation in Australia and internationally. The project will assess whether MTAs are reflecting the open data access movement or maintaining traditional closed proprietary practices. The project will make policy, ethical and legal recommendations for the development of MTAs to promote exchange of materials nationally and internationally and to facilitate the developing collaborative research culture. Read moreRead less
Genomic data sharing: issues in law, research ethics and society. This project aims to provide recommendations for best practice regulation and governance of genomic data sharing in Australia. Sharing of genomic data is essential to biomedical research and clinical practice. Scenarios will be used to map legal and quasi legal facilitators issues including barriers to sharing, and to assess their role in promoting public trust, using evidence-based processes and law reform methodology. Developin ....Genomic data sharing: issues in law, research ethics and society. This project aims to provide recommendations for best practice regulation and governance of genomic data sharing in Australia. Sharing of genomic data is essential to biomedical research and clinical practice. Scenarios will be used to map legal and quasi legal facilitators issues including barriers to sharing, and to assess their role in promoting public trust, using evidence-based processes and law reform methodology. Developing more effective and efficient regulation of genomic data sharing will promote public trust and encourage broader data sharing, facilitating scientific progress and delivery of precision medicine.Read moreRead less
The age of personalised medicine: regulatory challenges for Australia. Australia is entering an age of personalised medicine where therapies and tests will be based on individual genetic profiles. This project aims to ensure that there is a best practice regulatory and governance environment for facilitating responsible research and clinical service delivery through a process of evidence-based regulatory reform.